81
39
Growth Score 81 in past quarter
-5 pts
Heat Score 39 in past quarter
-12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
1540869
Over 4 million Americans who are at risk for blood clots currently take some form of blood thinner.
Ryan Bloom: FounderPast Role: Narus Biotechnologies, Cofounder
About the Company
Over 4 million Americans who are at risk for blood clots currently take some form of blood thinner. Complications due to improper management or dosing of these drugs amount to over $5 billion in healthcare spending in the U.S. every year. Factor 14 is developing both hardware and software to help healthcare providers manage these patients remotely,
reducing healthcare costs and improving patient outcomes.
